VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 28 filers reported holding VASCULAR BIOGENICS LTD in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,359,000 | -3.9% | 12,365 | 0.0% | 0.09% | +17.1% |
| Q3 2021 | $25,348,000 | -12.7% | 12,365 | +1.7% | 0.08% | -15.6% |
| Q2 2021 | $29,050,000 | -45.6% | 12,155 | -54.5% | 0.09% | -46.7% |
| Q1 2021 | $53,370,000 | -33.2% | 26,685 | -54.9% | 0.17% | -10.6% |
| Q1 2020 | $79,930,000 | +66.4% | 59,208 | +47.9% | 0.19% | +182.1% |
| Q4 2019 | $48,036,000 | – | 40,030 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
| Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
| DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
| PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
| Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
| Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
| HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
| MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
| Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |